Emerging drugs for the treatment of idiopathic pulmonary fibrosis: 2020 phase II clinical trials

Giacomo Sgalla, Marialessia Lerede, Luca Richeldi

Risultato della ricerca: Contributo in rivistaEditoriale in rivista / quotidiano

Fingerprint

Entra nei temi di ricerca di 'Emerging drugs for the treatment of idiopathic pulmonary fibrosis: 2020 phase II clinical trials'. Insieme formano una fingerprint unica.

Pharmacology, Toxicology and Pharmaceutical Science